Do true remissions in myasthenia really exist? An electrophysiological study

Area of Science:

• Neurology
• Clinical Electrophysiology

Background:

• Myasthenia gravis is an autoimmune disorder affecting neuromuscular transmission.
• The definition and occurrence of true remissions in myasthenia gravis remain debated.

Purpose of the Study:

• To investigate the presence of subclinical neuromuscular transmission abnormalities in patients with myasthenia gravis who are in clinical remission.
• To determine if clinical remission equates to complete physiological recovery.

Main Methods:

• Single-fiber electromyography (SFEMG) was used to assess neuromuscular transmission.
• Patients in clinical remission were compared with healthy volunteers and active myasthenia gravis patients.

Main Results:

• 17 out of 20 patients in remission exhibited SFEMG abnormalities, indicating subclinical neuromuscular disturbances.
• Abnormalities in the remission group were less pronounced than in active myasthenia gravis patients.
• A case study demonstrated a clinical relapse following a period of remission, correlating with SFEMG findings.

Conclusions:

• Clinical remission in myasthenia gravis may be only apparent, with underlying subclinical neuromuscular dysfunction persisting.
• Pathological SFEMG findings in remission warrant heightened clinical vigilance and management adjustments.
• Further investigation into long-term outcomes and management strategies for patients with subclinical abnormalities is recommended.